Related Experiment Video
Updated: Jun 5, 2026

09:52
Accurate and Simple Evaluation of Vascular Anastomoses in Monochorionic Placenta using Colored Dye
Published on: September 5, 2011
Chorangioma placentae.
Cvjetko Lež1, Rajko Fures, Zlatko Hrgovic
1Department of Pathology and Cytology, General Hospital Zabok, Zabok, Croatia.
Rare Tumors
|January 15, 2011
Summary
Placental chorangiomas are rare tumors, typically small and clinically insignificant. This case highlights an uncommon presentation where a large chorangioma did not cause pregnancy complications or fetal anomalies.
Area of Science:
- Obstetrics
- Gynecologic Pathology
- Fetal Medicine
Background:
- Chorangioma of the placenta is a rare tumor, occurring in approximately 1% of pregnancies.
- These tumors typically present as solitary or multiple nodules on the fetal placental surface or within the placental parenchyma.
- While most chorangiomas are small and clinically insignificant, larger or multiple tumors (>5 cm) can be associated with pregnancy complications.
Observation:
- This report details an uncommon case of placental chorangioma.
- The chorangioma presented with significant size.
- Notably, the presence and size of this chorangioma were not linked to any pregnancy disorders.
Findings:
- The case demonstrates a placental chorangioma unassociated with adverse pregnancy outcomes.
- Fetal development was normal, with no detected developmental anomalies.
- This finding challenges the typical association between large chorangiomas and pregnancy complications.
Implications:
- This case expands the understanding of placental chorangioma presentations.
- It suggests that not all large chorangiomas necessitate intervention if the pregnancy is otherwise uncomplicated.
- Further research may elucidate the specific factors determining chorangioma clinical significance.
Related Concept Videos
Development of Blood Vessels
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
Fetal Circulation
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
